ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
批准号:
10373627
负责人:
Ashok Kumar
金额:
$23.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-13 至 2024-04-30
关键词:
AblationAdenosineAdenovirus VectorAdultAffectAmino Acid SequenceAntiviral ResponseAntiviral TherapyAtrophicAttenuatedAutoimmune DiseasesBindingBinding ProteinsBlood VesselsBlood-Retinal BarrierCellsClinicalCodeCre lox recombination systemDRADA2b proteinDataDouble-Stranded RNAEndothelial CellsEndotheliumEnzymesEventEyeEye diseasesFlavivirusFunctional disorderGene DeliveryGene Expression RegulationGenesGenetic TranscriptionGoalsGuanosineHistologyHumanImmune responseInfantInfectionInflammationInflammatoryInflammatory ResponseInnate Immune ResponseInosineInterferonsKnowledgeLaboratoriesLeadLentivirusLongitudinal StudiesMalignant NeoplasmsMediatingMessenger RNAModalityMusNatural ImmunityOcular PathologyPathogenesisPathologicPathologyPatternPlasmidsPlayPost-Transcriptional RegulationProductionPropertyProteinsProteomePublic HealthRNARNA EditingRNA IRNA SplicingRNA VirusesRNA-specific adenosine deaminase 3Replication-Associated ProcessReportingRetinaRoleSignal TransductionSiteStructure of retinal pigment epitheliumTestingTranscriptTranslationsVaccinesViralViral GenomeViral load measurementVirus DiseasesVirus ReplicationVisual impairmentZIKV infectionZika Virusadenosine deaminasebasecytokinedsRNA adenosine deaminaseeconomic implicationfundus imaginggenome analysisgenome-widehuman pathogenimmune activationin vivoknock-downmRNA Precursormouse modelmutantneonatal micenovel therapeuticsoverexpressionpathogenpreventrational designresponsesocial implicationtherapeutic targettranscriptometranscriptome sequencingtranscriptomicsviral RNAwhole genome
中文摘要
项目摘要
作为对病毒感染的反应,宿主细胞触发先天/抗病毒免疫反应,
主要通过产生干扰素(IFN)和干扰素刺激基因(ISGs)。这些反-
病毒反应促进炎症、免疫细胞激活和病毒清除。我们最近
据报道,视网膜色素上皮(RPE)和视网膜血管或脉络膜内皮细胞
对寨卡病毒(ZIKV)感染高度许可,并通过增加
生产综合框架网络和综合服务指南。ZIKV感染的RPE的转录分析显示
作用于RNA1的腺苷脱氨酶(ADAR1)是一种强大的ISG,它能在体内发挥促肾上腺皮质激素的作用。
或通过对宿主和病毒RNA进行A-to-I编辑来实现抗病毒活性。行动的作用和机制
到目前为止,对ZIKV过程中ADAR1及相关黄病毒的研究尚不多见。我们的预赛
研究表明:1)ADAR1在转录本以及ZIKV上的蛋白水平上调
感染RPE细胞,2)ADAR1过表达减少,而ADAR1被敲除
RPE细胞中ZIKV复制增加。这些发现促使我们研究ADAR1的作用
在视网膜对ZIKV和其他黄病毒的先天免疫中。因此,这项提案的总体目标是
ADAR1抑制RPE中ZIKV复制的作用机制研究
细胞(目标1);以及确定ADAR1消融和ADAR1过表达的后果
关于ZIKV诱导的小鼠脉络膜视网膜萎缩模型(目标2)。拟议的研究将
拓宽和深化我们对眼部ZIKV感染过程中的抗病毒反应的认识。我们的
研究还可以基于RNA编辑能力确定新的靶点和治疗方式
主人的名字。
英文摘要
Project Summary
In response to viral infections, host cells trigger an innate/anti-viral immune response,
predominantly by producing the interferons (IFNs) and IFN-stimulated genes (ISGs). These anti-
viral responses promote inflammation, immune cell activation, and viral clearance. We recently
reported that retinal pigment epithelium (RPE) and retinal vascular or choroidal endothelium are
highly permissive to Zika virus (ZIKV) infection and elicit antiviral response with increased
production of IFNs and ISGs. The transcriptomic analysis of ZIKV-infected RPE revealed the
induction of adenosine deaminases acting on RNA1 (ADAR1), a potent ISG, which can exert pro-
or antiviral activity by A-to-I editing of the host and viral RNA. The role and mechanisms of action
of ADAR1 during ZIKV and related flaviviruses have not been studied till now. Our preliminary
studies show that 1) ADAR1 is up-regulated at the transcript, as well as, protein levels upon ZIKV
infection in RPE cells, and 2) ADAR1 overexpression reduced, while ADAR1 knockdown
increased, ZIKV replication in RPE cells. These findings led us to investigate the role of ADAR1
in retinal innate immunity to ZIKV and other flaviviruses. Thus, the overall goal of this proposal is
to determine the mechanisms of antiviral actions of ADAR1 in attenuating ZIKV replication in RPE
cells (Aim 1); and to determine the consequences of ADAR1 ablation and ADAR1 overexpression
on ZIKV-induced chorioretinal atrophy in a mouse model (Aim 2). The proposed studies will
broaden and deepen our knowledge of the antiviral response during ocular ZIKV infection. Our
studies could also identify new targets and treatment modalities based on the RNA editing ability
of the host.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADAR1-mediated antiviral response in Zika virus (ZIKV) infection
-
批准号:10621913
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2022
-
负责人:Ashok Kumar
-
依托单位:
Age-associated impaired executive function: Rescue by NMDA receptor upregulation
-
批准号:10033493
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2020
-
负责人:Ashok Kumar
-
依托单位:
Role of ABCG1 in Zika virus induced chorioretinal atrophy
-
批准号:9436896
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2018
-
负责人:Ashok Kumar
-
依托单位:
Role of AMP-activated protein kinase in bacterial endophthalmitis - Diversity Supplement
-
批准号:10206590
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2017
-
负责人:Ashok Kumar
-
依托单位:
Role of AMP-activated protein kinase in bacterial endophthalmitis
-
批准号:9899998
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2017
-
负责人:Ashok Kumar
-
依托单位:
Targeting NAD metabolism to ameliorate bacterial endophthalmitis
-
批准号:10445516
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2017
-
负责人:Ashok Kumar
-
依托单位:
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis
-
批准号:10231125
-
项目类别:
-
资助金额:$37.35万
-
财政年份:2017
-
负责人:Ashok Kumar
-
依托单位:
Mechanisms of Inflammation Resolution in Bacterial Endophthalmitis
-
批准号:10002232
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2017
-
负责人:Ashok Kumar
-
依托单位:
Targeting NAD metabolism to ameliorate bacterial endophthalmitis
-
批准号:10621770
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2017
-
负责人:Ashok Kumar
-
依托单位:
Toll-like receptors and bacterial endophthalmitis
-
批准号:8387011
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2010
-
负责人:Ashok Kumar
-
依托单位:
Toll-like receptors and bacterial endophthalmitis
-
批准号:8008778
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2010
-
负责人:Ashok Kumar
-
依托单位:
Toll-like receptors and bacterial endophthalmitis
-
批准号:7767863
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2010
-
负责人:Ashok Kumar
-
依托单位:
Toll-like receptors and bacterial endophthalmitis
-
批准号:8585851
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2010
-
负责人:Ashok Kumar
-
依托单位:
Toll-like receptors and bacterial endophthalmitis
-
批准号:8534384
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2010
-
负责人:Ashok Kumar
-
依托单位:
Toll-like receptors and bacterial endophthalmitis
-
批准号:8206829
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2010
-
负责人:Ashok Kumar
-
依托单位:
Immunology (I) Core
-
批准号:10703393
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1997
-
负责人:Ashok Kumar
-
依托单位:
Immunology (I) Core
-
批准号:10000933
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1997
-
负责人:Ashok Kumar
-
依托单位:
Immunology (I) Core
-
批准号:10238882
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1997
-
负责人:Ashok Kumar
-
依托单位:
Immunology (I) Core
-
批准号:10475061
-
项目类别:
-
资助金额:$10.81万
-
财政年份:1997
-
负责人:Ashok Kumar
-
依托单位:
国内基金
海外基金
基于ADK/Adenosine调控DNA甲基化探讨“利湿化瘀通络”法对2型糖尿病肾病足细胞裂孔膜损伤的干预机制研究
-
批准号:82074359
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:安晓飞
-
依托单位:
细胞外腺苷(Adenosine)作为干细胞旁分泌因子的生物学鉴定和功能分析
-
批准号:81570244
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:丁兆平
-
依托单位:
Adenosine诱导A1/A2AR稳态失衡启动慢性低灌注白质炎性损伤及其机制
-
批准号:81171113
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2011
-
负责人:黄文
-
依托单位: